SE9902387D0 - New pharmaceutically active compounds - Google Patents

New pharmaceutically active compounds

Info

Publication number
SE9902387D0
SE9902387D0 SE9902387A SE9902387A SE9902387D0 SE 9902387 D0 SE9902387 D0 SE 9902387D0 SE 9902387 A SE9902387 A SE 9902387A SE 9902387 A SE9902387 A SE 9902387A SE 9902387 D0 SE9902387 D0 SE 9902387D0
Authority
SE
Sweden
Prior art keywords
6alkyl
optionally substituted
active compounds
pharmaceutically active
new pharmaceutically
Prior art date
Application number
SE9902387A
Other languages
English (en)
Swedish (sv)
Inventor
Kostas Karabelas
Matti Lepistoe
Peter Sjoe
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9902387A priority Critical patent/SE9902387D0/xx
Publication of SE9902387D0 publication Critical patent/SE9902387D0/xx
Priority to EP00946631A priority patent/EP1192150A1/en
Priority to PCT/SE2000/001336 priority patent/WO2000078750A1/en
Priority to AU60361/00A priority patent/AU6036100A/en
Priority to JP2001504916A priority patent/JP2003502420A/ja
Priority to US09/743,618 priority patent/US6492409B1/en
Priority to US10/288,329 priority patent/US20030134886A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE9902387A 1999-06-22 1999-06-22 New pharmaceutically active compounds SE9902387D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9902387A SE9902387D0 (sv) 1999-06-22 1999-06-22 New pharmaceutically active compounds
EP00946631A EP1192150A1 (en) 1999-06-22 2000-06-22 New pharmaceutically active compounds
PCT/SE2000/001336 WO2000078750A1 (en) 1999-06-22 2000-06-22 New pharmaceutically active compounds
AU60361/00A AU6036100A (en) 1999-06-22 2000-06-22 New pharmaceutically active compounds
JP2001504916A JP2003502420A (ja) 1999-06-22 2000-06-22 新たな薬学的に活性な化合物
US09/743,618 US6492409B1 (en) 1999-06-22 2000-06-22 Kinase inhibitors
US10/288,329 US20030134886A1 (en) 1999-06-22 2002-11-06 Pharmaceutically active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902387A SE9902387D0 (sv) 1999-06-22 1999-06-22 New pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
SE9902387D0 true SE9902387D0 (sv) 1999-06-22

Family

ID=20416210

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902387A SE9902387D0 (sv) 1999-06-22 1999-06-22 New pharmaceutically active compounds

Country Status (6)

Country Link
US (2) US6492409B1 (ja)
EP (1) EP1192150A1 (ja)
JP (1) JP2003502420A (ja)
AU (1) AU6036100A (ja)
SE (1) SE9902387D0 (ja)
WO (1) WO2000078750A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045595A1 (es) * 2003-09-04 2005-11-02 Vertex Pharma Composiciones utiles como inhibidores de proteinas quinasas
AU2004308441A1 (en) * 2003-12-24 2005-07-14 Wyeth Methods of treating asthma
CA2618724A1 (en) 2005-08-18 2007-02-22 Synta Pharmaceuticals Corp. Imidazole compounds that modulate hsp90 activity
WO2007139951A2 (en) 2006-05-25 2007-12-06 Synta Pharmaceuticals Corp. Method for treating proliferative disorders associated with protooncogene products
EP2560640A1 (en) 2010-04-19 2013-02-27 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
JP2014532712A (ja) 2011-11-02 2014-12-08 シンタ ファーマシューティカルズ コーポレーション トポイソメラーゼｉ阻害剤とｈｓｐ９０阻害剤の組合せを使用する癌療法
WO2013067165A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with platinum-containing agents
CA2854188A1 (en) 2011-11-14 2013-05-23 Synta Pharmaceuticals Corp. Combination therapy of hsp90 inhibitors with braf inhibitors
RU2720490C1 (ru) * 2019-11-05 2020-04-30 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) 3-(2-оксоимидазолидинил-5)индолы и способ их получения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3141063A1 (de) 1981-10-13 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPS647365A (en) 1987-06-30 1989-01-11 Toshiba Corp Magnetic head device for floppy disk device
JP2722586B2 (ja) * 1989-01-13 1998-03-04 大正製薬株式会社 インドリルイミダゾール誘導体
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos

Also Published As

Publication number Publication date
WO2000078750A1 (en) 2000-12-28
US6492409B1 (en) 2002-12-10
EP1192150A1 (en) 2002-04-03
AU6036100A (en) 2001-01-09
JP2003502420A (ja) 2003-01-21
US20030134886A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
SE9900961D0 (sv) Novel compounds
SE0101387D0 (sv) Novel compounds
EA200200208A1 (ru) Синергитическая композиция
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EA200200571A1 (ru) Новая композиция и ее применение
DE60112974D1 (en) Carbolinderivate
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE9802208D0 (sv) Novel compounds
GEP20022654B (en) Indazole Amide Compounds As Serotoninergic Agents
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
SE9903997D0 (sv) New compounds
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
SE9902387D0 (sv) New pharmaceutically active compounds
DE60112960D1 (de) Kondensierte pyridoindolderivate
HUP0300298A2 (hu) 4-[Piperazinil-8-(kinolinil-metil)]benzamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE253359T1 (de) Antithrombotische mittel
SE9802209D0 (sv) Novel compounds
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine